Imagine a world where women with adenomyosis, a common yet challenging condition, can preserve their fertility and have successful pregnancies. This is the promise of fertility-sparing interventions, but the question remains: do these treatments deliver on their promise?
In this comprehensive review, we delve into the world of adenomyosis and the interventions designed to preserve fertility. We explore the latest research, uncovering the potential and pitfalls of these treatments.
The results are promising, with successful pregnancies and deliveries observed across various treatment groups. However, there are some important considerations. For instance, the high cesarean section rate and elevated rates of preterm delivery and adverse pregnancy outcomes after adenomyomectomy compared to thermal ablation.
But here's where it gets controversial: the impact of uterine artery embolization (UAE) on fertility is still up for debate. While some studies suggest it may not be the best option for women seeking pregnancy, others show more positive outcomes.
And this is the part most people miss: the impact of these interventions on ovarian reserve. While some treatments seem to have no adverse effects, others, like UAE, may affect ovarian function.
So, while the future looks bright for women with adenomyosis, there are still some uncertainties and controversies to navigate. But with ongoing research and advancements in medical technology, we're getting closer to finding the best solutions.
What do you think? Do these findings match your expectations? Let's discuss in the comments!
